Johnson & Johnson today honors the winners of the 2012 Dr. Paul Janssen Award for Biomedical Research in a ceremony and scientific symposium at the New York Academy of Sciences in New York, NY. Victor Ambros, Ph.D., of the University of Massachusetts Medical School, and Gary Ruvkun, Ph.D., of Massachusetts General Hospital and Harvard Medical School, received the award for their collaborative discovery of microRNAs (miRNAs) as central regulators of gene expression and development, and will share a $100,000 prize.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58019-johnson-and-johnson-jnj-2012-dr-paul-janssen-award-for-biomedical-research
Launching today, Save the Children and Ad Council’s Every Beat Matters™ campaign draws on the power of music inspired by children’s heartbeats to give Americans new ways to help millions more children survive.
Multimedia public service ads featuring the creation of OneRepublic’s new single “Feel Again” debut today and will be distributed to more than 33,000 media outlets nationwide. The ads—created pro bono by ad agency BBDO New York and filmed by Academy Award-nominated directors Sean and Andrea Fine—show how children’s heartbeats collected in remote villages of Malawi and Guatemala inspired a hit song that can help bring hope to children around the world.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58026-ad-council-save-the-children-every-beat-matters-onerepublic-feel-again
Seventy-five (75) percent of people with dementia and 64 percent of caregivers believe there are negative associations for those diagnosed with dementia in their countries, according to survey fielded by Alzheimer’s Disease International and published today in the World Alzheimer Report 2012: Overcoming the Stigma of Dementia. The report was released on Alzheimer’s Action Day as part of World Alzheimer’s Month activities engaging people in the cause and raising awareness about the disease.
In response, Alzheimer’s Association® Early-Stage Advisors, men and women from across the U.S. living with the disease, and their caregivers developed tips on how to cope with the stigma surrounding Alzheimer’s based on their personal experiences.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57800-world-alzheimer-report-2012-overcoming-negative-stigma-dementia
Mimi’s Cafe® announces its partnership with National Breast Cancer Foundation (NBCF) and launches the Mimi’s Power of Pink campaign in October, Breast Cancer Awareness Month. All 145 Mimi’s locations will raise awareness and funds in support of NBCF’s mission to save lives through early detection and by providing mammograms for women in need. Mimi’s kicks off the campaign Oct. 1 with a special offer: Wear pink to Mimi’s and receive a FREE seasonal Pumpkin Spiced Muffin with any purchase. There will be more ways to participate throughout the month.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58344-mimi-s-cafe-power-of-pink-national-breast-cancer-awareness-month-october
OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional™ nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex® nasal spray (AUC 0-15 = 1.69 ng*hr/mL and 1.04 ng*hr/mL, respectively). The OptiNose technology achieved this improved effect despite delivering 20% less drug into the nose (16mg) than the Imitrex® liquid nasal spray (20mg).
To view Multimedia News Release, go to http://www.multivu.com/players/English/57713-optinose-innovative-breath-powered-nasal-delivery-technology-delivers-drugs-to-treat-variety-of-medical-conditions
Phenogen Sciences, Inc. [www.phenogensciences.com] today announced the immediate availability of BREVAGen™, a predictive risk test for the millions of women at above average risk of developing estrogen-receptor positive breast cancer. This first-in-class, scientifically-validated risk assessment test examines a woman’s clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient’s personalized five-year and lifetime risk of developing breast cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58399-phenogen-sciences-brevagen-breast-cancer-risk-assessment-test-availability
In recognition of Metastatic Breast Cancer Awareness Day on October 13, AstraZeneca (NYSE: AZN) is raising awareness about the thousands of U.S. women living with metastatic breast cancer. Metastatic Breast Cancer Awareness Day seeks to generate attention and greater support for women living with metastatic breast cancer among the public and stakeholders within the breast cancer community and more research to extend lives.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58129-mbc-awareness
In the lead-up to Lung Cancer Awareness Month this November, the ‘future face’ of women’s cancer is being revealed. While new data published last month by Cancer Research UK suggests the number of women dying from breast cancer in the UK is in decline – expected to drop almost 30 percent by 2030 – the number of women dying from lung cancer is on the increase.
Liz Darlison, Macmillan Consultant Nurse Specialist, University Hospitals of Leicester, says, “While the statistics paint a frightening picture, there’s a great deal that can be done to help ensure women are diagnosed earlier, treated earlier and live longer. By raising awareness of the tell-tale signs – for example, a persistent cough that lasts longer than three weeks – there’s the potential to save thousands of lives every year.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/56634-lilly-uk-lung-cancer-awareness
To help combat an increasing trend in festive isolation, charity Abbeyfield today launches a nationwide campaign, Companionship At Christmas, to create an alternative to spending the celebratory period alone. The charity is offering free overnight stays and delicious Christmas lunches over the festive season (24th December – 4th January) in over 100 Abbeyfield sheltered houses and care homes. The Charity will take enquiries from now until December via their website or via their dedicated telephone number 0845 052 3553 up until the 18th December.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58633-abbeyfield-launches-companionship-at-christmas-campaign
Research led by the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis.
The finding offers the first evidence of a mistake that gives rise to a significant percentage of acute megakaryoblastic leukemia (AMKL) cases in children. AMKL accounts for about 10 percent of pediatric acute myeloid leukemia (AML). The discovery paves the way for desperately needed treatment advances.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58586-st-jude-children-s-research-hospital-gene-sequencing-childhood-leukemia
Golden Globe and Emmy nominated actress Elizabeth Perkins, who is living with type 1 diabetes, is partnering with Sanofi US on the Diabetes Co-Stars awareness campaign to produce a new documentary that will feature people living with diabetes and those who support them. Beginning today through December 16, 2012, people can submit their stories to the nationwide casting call at www.DiabetesCoStars.com.
To view Multimedia News Release, go to https://www.multivu.com/mnr/57457-sanofi-us-elizabeth-perkins-casting-call-diabetes-co-stars-documentary
